Gossamer Bio, Inc.
GOSSA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
A recent price could not be verified. Check the exchange before trading.
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Company calendar
Gossamer Bio 1-for-80 reverse split effective time
Gossamer Bio's reverse split, combining every 80 common shares into one, is expected to become effective at 11:59 PM ET on 10 September. Split-adjusted Nasdaq trading is planned for the 11 September market open.
Gossamer Bio ↗Gossamer Bio split-adjusted Nasdaq trading
Gossamer Bio shares are expected to begin split-adjusted trading at the Nasdaq market open on 11 September following the 1-for-80 reverse split. The GOSS ticker will remain unchanged; the new CUSIP will be 38341P201. Fractional shares will be rounded up to the nearest whole share.
Gossamer Bio ↗More NASDAQ records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.